La catena delle opzioni mostra i dati chiave delle opzioni azionarie di BioAtla a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per BioAtla..

BioAtla (NASDAQ:BCAB) Azioni, Catena delle Opzioni

BioAtla

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

BioAtla Inc

<p>Keefe, Bruyette &amp; Woods  analyst Vasundhara Govil   maintains Fidelity National Info (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) with a Outperform and raises the price target from $97 to $102.</p>


News

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Outperform on Fidelity National Info, Raises Price Target to $102

WIIM

DXPE

DXP Enterprises shares are trading higher after the company reported better-than-expected Q3 financial results.

<p>The U.S. services sector's economic momentum is firing at all cylinders, with business activity in October reaching its strongest level <a href="https://www.benzinga.com/news/econ-s">in over two years.</a></p>
<p>According to the Institute for Supply Management, the Services PMI surged to 56% in October 2024, up from 54.9% in September, defying expectations of a dip to 53.8%.</p>
<p>This result marks the fastest pace of expansion in the U.S. services sector since August 2022. The ISM Services PMI has shown growth in 20 of the past 22 months since January 2023, with October's reading standing 3.7 percentage points above the 2024 average of 52.3%.</p>
<p>&#8220;The increase in the Services PMI&nbsp;in October was driven by boosts of more than 4 percentage points for both the Employment and Supplier Deliveries indexes. The Business Activity and New Orders indexes both dropped by at least 2 percentage points. Each of the four subindexes are now above their averages for 2024,&#8221; stated <strong>Steve Miller</strong>, chair of the ISM Services Business Survey Committee, said.</p>
<h3 class="wp-block-heading">ISM Services PMI For October: Key Highlights</h3>
<ul>
<li>The subindex for Business Activity eased from 59.9% to 57.2% in October.</li>
<li>The subindex for New Orders eased from 59.4% to 57.4% in October. </li>
<li>The subindex for Prices eased from 59.4% to 58.1%. </li>
<li>The subindex for Employment rose from 48.1% to 53%, well above the expected 48%. The outcome marked the highest level in employment index since September 2023. </li>
</ul>
<p>&#8220;Concerns over political uncertainty were again more prevalent than the previous month. Impacts from hurricanes and ports labor turbulence were mentioned frequently, although several panelists mentioned that the longshoremen's strike had less of an impact than feared due to its short duration,&#8221; Miller added. </p>
<h3 class="wp-block-heading">Market Reactions</h3>
<p>On Tuesday, U.S. stocks rebounded as investors reacted positively to the latest ISM Services PMI data, alleviating earlier political concerns as Americans headed to the polls to elect the 47th president.</p>
<p>The S&amp;P 500, represented by the <strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), rose 0.8%. The tech-heavy Nasdaq 100, tracked by the <strong>Invesco QQQ Trust </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), rallied nearly 1%, while the <strong>SPDR Dow Jones Industrial Average ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) edged 0.6% higher.</p>
<p>Yields on 10-year Treasury bonds rose 7 basis points to 4.36%. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) fell 0.5%. </p>
<p>The U.S. dollar index — as tracked by the  <strong>Invesco DB USD Index Bullish Fund ETF </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) — weakened 0.5%.</p>
<p><strong>Now Read:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/asia/24/11/41722178/if-trump-and-republicans-sweep-dollar-may-climb-7-but-harris-win-could-bring-5-drop-says-jpmorgan">If Trump And Republicans Sweep, Dollar May Climb 7% — But Harris Win Could Bring 5% Drop, Says JPMorgan</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Macro Economic Events

Bonds

Broad U.S. Equity ETFs

Treasuries

Econ #s

Economics

ETFs

SPDR Dow Jones Industrial Average ETF Trust

iShares Trust Barclays 20+ Year Treasury Bond Fund

PowerShares DB US Dollar Index Bullish Fund

US Services Sector Gauge Rises More Than Expected To Over 2-Year Highs As Employment Index Defies Hurricane Shocks

Cushman & Wakefield shares are trading higher after the company reported better-than-expected Q3 adjusted EPS results.

REAL

The RealReal shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 revenue guidance above estimates.

<p>JP Morgan  analyst Tien-Tsin Huang   maintains Marqeta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MQ#NASDAQ">MQ</a>) with a Neutral and lowers the price target from $6 to $5.</p>


JP Morgan Maintains Neutral on Marqeta, Lowers Price Target to $5

<p>Keefe, Bruyette &amp; Woods  analyst Aidan Hall   reiterates Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) with a Underperform and lowers the price target from $20 to $19.</p>


Reiteration

Keefe, Bruyette & Woods Reiterates Underperform on Franklin Resources, Lowers Price Target to $19

<p>RBC Capital  analyst Luca Issi   maintains Adverum Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) with a Sector Perform and lowers the price target from $12 to $10.</p>


ADVM

RBC Capital Maintains Sector Perform on Adverum Biotechnologies, Lowers Price Target to $10

BWIN

The Baldwin Insurance Group shares are trading lower after the company reported worse-than-expected Q3 financial results. Also, Wells Fargo maintained an Equal-Weight rating on the stock and lowered its price target from $46 to $43.

<p>JP Morgan  analyst Anne Samuel   maintains IQVIA Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) with a Overweight and lowers the price target from $279 to $240.</p>


JP Morgan Maintains Overweight on IQVIA Hldgs, Lowers Price Target to $240

Hyster-Yale shares are trading lower after the company reported worse-than-expected Q3 financial results. The company also issued expectations for FY25 revenues to be lower than 2024 and for operating profit and net income to decline significantly.

<p>Keefe, Bruyette &amp; Woods  analyst Kyle Voigt   maintains Brookfield Asset Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAM#NYSE">BAM</a>) with a Underperform and raises the price target from $44 to $49.</p>


Keefe, Bruyette & Woods Maintains Underperform on Brookfield Asset Mgmt, Raises Price Target to $49

<p>JP Morgan  analyst Kenneth Worthington   maintains Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) with a Neutral and lowers the price target from $22 to $21.</p>


JP Morgan Maintains Neutral on Franklin Resources, Lowers Price Target to $21

UFPT

UFP Technologies shares are trading higher after the company reported better-than-expected Q3 financial results.

<p><strong>Blink Charging Co.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Tuesday.</a></p>
<p>Today, the company has unveiled the creation of a Special Purpose Vehicle (SPV) designed to expand EV charging infrastructure<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41745007/blink-to-establish-a-100-million-special-purpose-vehicle-to-drive-electric-vehicle-charger-investm" rel="noreferrer noopener"> in the U.K. and beyond.</a></p>
<p>The SPV aims to raise an initial £100 million ($130.10 million), offering investors the chance to capitalize on the rapidly growing EV infrastructure market.</p>
<p>To kick off the project, Blink has partnered with Axxeltrova Capital, a private equity firm focused on digital infrastructure, renewable energy, and sustainable investments. This makes it the SPV&#8217;s first funding partner.</p>
<p>&#8220;While we are in the early stages and agreements are still being formalized, the potential for growth in the EV sector is unmistakable,&#8221; said Mike Battaglia, CEO-Elect of Blink Charging.</p>
<p>&#8220;We invite other investors to join us in this exciting opportunity to shape the future of electric mobility.&#8221;</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41748807/thomson-reuters-q3-earnings-legal-corporate-segments-enjoy-revenue-boost-as-ceo-highlights-ai-inves" rel="noreferrer noopener">Thomson Reuters Q3 Earnings: Legal, Corporate Segments Enjoy Revenue Boost As CEO Highlights AI Investment</a></strong></p>
<p>The SPV&#8217;s structure is designed to attract further investments, enabling Blink to deploy significant capital to expand accessible charging networks.</p>
<p>The SPV targets projects eligible for subsidies through the UK&#8217;s Local Electric Vehicle Infrastructure (LEVI) funding.</p>
<p>Recently, the firm disclosed that it has received a nearly $2 million grant from the Illinois&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41624237/blink-charging-awarded-2-million-grant-to-provide-ev-chargers-for-state-of-illinois" rel="noreferrer noopener">Environmental Protection Agency</a>.</p>
<p>This funding will enable Blink to own and operate EV chargers in the state of Illinois, facilitating public charging solutions for employees, residents, and visitors.</p>
<p>Under this grant, the Illinois EPA will cover part of the eligible expenses for new commercial-grade DC Fast Chargers and Alternating Current Level 2 charging stations to be installed at publicly accessible locations throughout Illinois.</p>
<p>Once completed, the project will feature 15 new Blink charging stations across five sites in Illinois, including 10 DC fast chargers with 180kW capacity and five Dual Port Level 2 stations (10 ports total). Blink is contributing a 30% cost share to the program.</p>
<p><strong>Price Action:&nbsp;</strong>BLNK shares are up 2.99%&nbsp;at&nbsp;$2.07&nbsp;at the last check Tuesday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/equities/24/10/41631517/blink-to-deploy-15-new-ev-charging-stations-in-illinois-backed-by-2-million-state-grant" target="_blank" rel="noreferrer noopener">Blink To Deploy 15 New EV Charging Stations In Illinois, Backed By $2 Million State Grant</a></strong></li>
</ul>


Equities

Markets

Movers

General

BLNK

What's Going On With Blink Charging Stock Tuesday?

<p>Financial giants have made a conspicuous bearish move on CrowdStrike Holdings. Our analysis of options history for CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) revealed 19 unusual trades.</p>
<p>Delving into the details, we found 26% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $449,009, and 8 were calls, valued at $674,910.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $185.0 and $340.0 for CrowdStrike Holdings, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for CrowdStrike Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across CrowdStrike Holdings's significant trades, within a strike price range of $185.0 to $340.0, over the past month.</p>
<h3>CrowdStrike Holdings Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730823366_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$120.3</td>
<td>$118.25</td>
<td>$118.25</td>
<td>$185.00</td>
<td>$260.1K</td>
<td style="text-align: right;">36</td>
<td style="text-align: right;">22</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$136.55</td>
<td>$126.65</td>
<td>$130.63</td>
<td>$220.00</td>
<td>$130.5K</td>
<td style="text-align: right;">112</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$81.8</td>
<td>$80.8</td>
<td>$81.8</td>
<td>$250.00</td>
<td>$81.8K</td>
<td style="text-align: right;">57</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$37.55</td>
<td>$37.25</td>
<td>$37.55</td>
<td>$310.00</td>
<td>$75.1K</td>
<td style="text-align: right;">545</td>
<td style="text-align: right;">20</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$33.8</td>
<td>$33.75</td>
<td>$33.8</td>
<td>$310.00</td>
<td>$67.6K</td>
<td style="text-align: right;">646</td>
<td style="text-align: right;">21</td>
</tr>
</tbody>
</table>
</p>
<h3>About CrowdStrike Holdings</h3>
<p>CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.</p>
<p>Following our analysis of the options activities associated with CrowdStrike Holdings, we pivot to a closer look at the company's own performance.</p>
<h3>CrowdStrike Holdings's Current Market Status</h3>
<ul>
<li>With a volume of 428,874, the price of CRWD is up 0.92% at $301.62. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>Expert Opinions on CrowdStrike Holdings</h3>
<p>In the last month, 2 experts released ratings on this stock with an average target price of $342.5.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Exane BNP Paribas has revised its rating downward to Neutral, adjusting the price target to $285.<br />
&#x2A; An analyst from JMP Securities downgraded its action to Market Outperform with a price target of $400. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for CrowdStrike Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

CRWD

This Is What Whales Are Betting On CrowdStrike Holdings

Yum! Brands shares are trading higher. The company reported Q3 financial results.

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>PDD Holdings</strong>.</p>
<p>Looking at options history for PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) we detected 37 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with bullish expectations and 54% with bearish.</p>
<p>From the overall spotted trades, 11 are puts, for a total amount of $1,051,483 and 26, calls, for a total amount of $2,542,190.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $110.0 and $190.0 for PDD Holdings, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for PDD Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across PDD Holdings's significant trades, within a strike price range of $110.0 to $190.0, over the past month.</p>
<h3>PDD Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730823361_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$6.05</td>
<td>$5.85</td>
<td>$5.85</td>
<td>$155.00</td>
<td>$818.9K</td>
<td>1.9K</td>
<td>1.4K</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$22.65</td>
<td>$22.6</td>
<td>$22.64</td>
<td>$135.00</td>
<td>$221.6K</td>
<td>2.5K</td>
<td>189</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$22.6</td>
<td>$22.55</td>
<td>$22.62</td>
<td>$135.00</td>
<td>$203.3K</td>
<td>2.5K</td>
<td>91</td>
</tr>
<tr>
<td>PDD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$39.65</td>
<td>$38.8</td>
<td>$39.35</td>
<td>$155.00</td>
<td>$196.7K</td>
<td>362</td>
<td>50</td>
</tr>
<tr>
<td>PDD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$35.6</td>
<td>$34.85</td>
<td>$35.4</td>
<td>$150.00</td>
<td>$177.0K</td>
<td>1.3K</td>
<td>50</td>
</tr>
</tbody>
</table>
</p>
<h3>About PDD Holdings</h3>
<p>PDD Holdings is a multinational commerce group that owns and operates a portfolio of businesses. PDD aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from the increased productivity and new opportunities. PDD has built a network of sourcing, logistics, and fulfillment capabilities that support its underlying businesses.</p>
<p>Following our analysis of the options activities associated with PDD Holdings, we pivot to a closer look at the company's own performance.</p>
<h3>PDD Holdings's Current Market Status</h3>
<ul>
<li>With a volume of 2,881,166, the price of PDD is up 0.27% at $122.64. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 21 days.</li>
</ul>
<h3>What The Experts Say On PDD Holdings</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $224.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Macquarie upgraded its action to Outperform with a price target of $224. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for PDD Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Citigourp Global Markets 2% Protected Notes Linked To The Djia

Decoding PDD Holdings's Options Activity: What's the Big Picture?

<p>RBC Capital  analyst Brian Abrahams   reiterates BioCryst Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) with a Outperform and maintains $10 price target.</p>


BCRX

RBC Capital Reiterates Outperform on BioCryst Pharma, Maintains $10 Price Target

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Newmont</strong>.</p>
<p>Looking at options history for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) we detected 12 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 16% of the investors opened trades with bullish expectations and 75% with bearish.</p>
<p>From the overall spotted trades, 7 are puts, for a total amount of $713,310 and 5, calls, for a total amount of $463,240.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $60.0 for Newmont, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Newmont options trades today is 5097.0 with a total volume of 2,750.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Newmont's big money trades within a strike price range of $30.0 to $60.0 over the last 30 days.</p>
<h3>Newmont Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730823356_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.5</td>
<td>$12.4</td>
<td>$12.5</td>
<td>$57.50</td>
<td>$352.5K</td>
<td>374</td>
<td style="text-align: right;">283</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$13.5</td>
<td>$13.3</td>
<td>$13.44</td>
<td>$35.00</td>
<td>$295.6K</td>
<td>5.0K</td>
<td style="text-align: right;">220</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$14.85</td>
<td>$14.75</td>
<td>$14.85</td>
<td>$60.00</td>
<td>$142.5K</td>
<td>2</td>
<td style="text-align: right;">97</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$18.85</td>
<td>$18.45</td>
<td>$18.7</td>
<td>$30.00</td>
<td>$56.1K</td>
<td>38</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.5</td>
<td>$12.4</td>
<td>$12.5</td>
<td>$57.50</td>
<td>$55.0K</td>
<td>374</td>
<td style="text-align: right;">328</td>
</tr>
</tbody>
</table>
</p>
<h3>About Newmont</h3>
<p>Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 5.5 million ounces of gold in 2024 from its core mines and 6.8 million in total. It is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.</p>
<p>Following our analysis of the options activities associated with Newmont, we pivot to a closer look at the company's own performance.</p>
<h3>Newmont's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,499,891, with NEM's price up by 0.2%, positioned at $45.85.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 107 days.</li>
</ul>
<h3>Expert Opinions on Newmont</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $59.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from UBS downgraded its rating to Neutral, setting a price target of $54.<br />
&#x2A; An analyst from Raymond James has decided to maintain their Outperform rating on Newmont, which currently sits at a price target of $66.<br />
&#x2A; Reflecting concerns, an analyst from Scotiabank lowers its rating to Sector Perform with a new price target of $55.<br />
&#x2A; An analyst from RBC Capital persists with their Sector Perform rating on Newmont, maintaining a target price of $53.<br />
&#x2A; An analyst from UBS persists with their Buy rating on Newmont, maintaining a target price of $67. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Newmont options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Newmont Unusual Options Activity For November 05

BioAtla GAAP EPS of -$0.44 in-line

BioAtla, Inc. (BCAB) Q2 2024 Earnings Call Transcript

BioAtla (BCAB – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Reni Benjamin from JMP Secur...

Reni Benjamin's Buy Rating for BioAtla: Strong Pipeline and Financial Health Signal Upside Potential

Michael Burry's Scion Asset sheds Safe Bulkers, adds Hudson Pacific, others in Q2

Justin Zelin, an analyst from BTIG, reiterated the Buy rating on BioAtla (BCAB – Research Report). The associated price target was raised to $13.00...

Buy Rating for BioAtla: Promising Pipeline and Strategic Partnerships Fuel Optimistic Outlook

Analyst Reni Benjamin of JMP Securities reiterated a Buy rating on BioAtla (BCAB – Research Report), retaining the price target of $5.00. Reni Benj...

Buy Rating Affirmed for BioAtla on Strong Clinical Data and Solid Financial Positioning

BioAtla out-licenses BA3362 to Context Therapeutics

Analyst Justin Zelin of BTIG maintained a Buy rating on BioAtla (BCAB – Research Report), retaining the price target of $13.00. Justin Zelin has gi...

Buy Rating Affirmed for BioAtla Amidst Strategic Collaborations and Promising Clinical Catalysts

BioAtla: Numerous Catalysts Coming In Q4

BioAtla's FDA Fast-Tracked Drug Candidate Boosts Its Oncology Prospects, Speculative Buy

BABA

BCAB

BIDU

CNTX

OLPX

PHYS

SBLK

Health Care

Press Releases

BioAtla Highlighted Clinical Program and Pipeline Updates at Virtual R&D Day

BioAtla to Announce Second Quarter 2024 Financial Results and Provide Business Highlights on August 8, 2024

Earnings

Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress

BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

BioAtla Announces Upcoming Poster Presentation at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting

BioAtla Presented Phase 2 Ozuriftamab Vedotin Clinical Trial Data Demonstrating Meaningful Antitumor Activity with Manageable Tolerability among Heavily Pretreated Patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN) at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody

Comments

BioAtla

BioAtla (BCAB) Opzioni

BioAtla (NASDAQ:BCAB) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO